Core Viewpoint - The China Feihe Dairy has launched the first application-oriented Human Milk Oligosaccharides (HMOs) full-spectrum structural database in China, which aims to enhance research efficiency and quality in the dairy industry [1][4]. Group 1: HMO Database Launch - The HMO database is characterized by its full spectrum, high precision, and strong practicality, addressing significant challenges in HMO detection and identification within the industry [1][2]. - The database enables precise analysis of 233 types of full-spectrum HMOs, significantly improving research speed and efficiency, marking a new era in HMO analysis [2][3]. Group 2: Industry Impact and Collaboration - Feihe's initiative fills a critical gap in HMO detection standards, providing a scientific basis for quality testing and supporting the development of new products in the industry [2][6]. - The database will be shared with the industry to facilitate efficient detection and analysis, promoting innovation and research collaboration among industry professionals [3][6]. Group 3: National Research Project - The HMO database is part of a national key research project under the "14th Five-Year Plan," which aims to enhance the understanding of breast milk and improve infant formula [3][6]. - Feihe has partnered with top universities and research institutions, investing nearly 100 million yuan to achieve significant breakthroughs in maternal and infant health research [6].
母乳研究国际领先！飞鹤(06186)发布中国首个应用型HMOs数据库 推动行业高质量发展